Tapewire

NYSE · USD

MET

METLIFE INC

Export transactions ↓
Tapewire entity
488
SEC CIK
0001099219
Parsed reports
1,091

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 25, 2025 Filed Feb 27, 2025 21:18 UTC
TADROS RAMYPresident, U.S. Business
GrantCommon Stock 44,959 Not disclosed Not disclosed
Disclosure

SEC source: 0001099219-25-000054 · wk-form4_1740691096.xml · nonDerivative · entry 2

TADROS RAMY · CIK 0001714199 · President, U.S. Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,276

F2 · price: Shares acquired from the determination of the performance factor for and payout of 2022-2024 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:18 UTC
TADROS RAMYPresident, U.S. Business
GrantCommon Stock 17,336 Not disclosed Not disclosed
Disclosure

SEC source: 0001099219-25-000054 · wk-form4_1740691096.xml · nonDerivative · entry 1

TADROS RAMY · CIK 0001714199 · President, U.S. Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,317

F1 · price: Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:41 UTC GrantCommon Stock 535 $0.00 $0.00
Disclosure

SEC source: 0001099219-25-000036 · wk-form4_1736199709.xml · nonDerivative · entry 1

GUTIERREZ CARLOS M · CIK 0001185943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,749

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:41 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-25-000035 · wk-form4_1736199698.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,875

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:41 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-25-000034 · wk-form4_1736199688.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,058

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:41 UTC GrantCommon Stock 535 $0.00 $0.00
Disclosure

SEC source: 0001099219-25-000033 · wk-form4_1736199678.xml · nonDerivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,805

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:41 UTC
Hay Laura JDirector
GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-25-000032 · wk-form4_1736199666.xml · nonDerivative · entry 1

Hay Laura J · CIK 0002013372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,558

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:41 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-25-000031 · wk-form4_1736199654.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,076

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:40 UTC GrantCommon Stock 535 $0.00 $0.00
Disclosure

SEC source: 0001099219-25-000030 · wk-form4_1736199644.xml · nonDerivative · entry 1

MORRISON DENISE M · CIK 0001230166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,715

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:40 UTC GrantCommon Stock 918 $81.78 $75,074.04
Disclosure

SEC source: 0001099219-25-000029 · wk-form4_1736199632.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,328

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:40 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-25-000028 · wk-form4_1736199621.xml · nonDerivative · entry 1

Johnson Jeh C. · CIK 0001707516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,604

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:40 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-25-000027 · wk-form4_1736199610.xml · nonDerivative · entry 1

Harris Carla A · CIK 0001707351 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,336

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:40 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-25-000026 · wk-form4_1736199599.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,667

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:39 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-25-000025 · wk-form4_1736199589.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,907

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:34 UTC GrantCommon Stock 33 $82.74 $2,730.42
Disclosure

SEC source: 0001099219-24-000288 · wk-form4_1734557635.xml · nonDerivative · entry 1

Johnson Jeh C. · CIK 0001707516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,069

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:33 UTC GrantCommon Stock 39 $82.74 $3,226.86
Disclosure

SEC source: 0001099219-24-000287 · wk-form4_1734557625.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,340

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:33 UTC GrantCommon Stock 271 $82.74 $22,422.54
Disclosure

SEC source: 0001099219-24-000286 · wk-form4_1734557614.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,372

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:33 UTC
Hay Laura JDirector
GrantCommon Stock 13 $82.74 $1,075.62
Disclosure

SEC source: 0001099219-24-000285 · wk-form4_1734557605.xml · nonDerivative · entry 1

Hay Laura J · CIK 0002013372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,023

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:33 UTC GrantCommon Stock 132 $82.74 $10,921.68
Disclosure

SEC source: 0001099219-24-000284 · wk-form4_1734557595.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,132

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:33 UTC GrantCommon Stock 536 $82.74 $44,348.64
Disclosure

SEC source: 0001099219-24-000283 · wk-form4_1734557584.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,541

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:32 UTC GrantCommon Stock 232 $82.74 $19,195.68
Disclosure

SEC source: 0001099219-24-000281 · wk-form4_1734557564.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,523

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:33 UTC GrantCommon Stock 579 $82.74 $47,906.46
Disclosure

SEC source: 0001099219-24-000282 · wk-form4_1734557574.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,410

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:32 UTC GrantCommon Stock 16 $82.74 $1,323.84
Disclosure

SEC source: 0001099219-24-000280 · wk-form4_1734557553.xml · nonDerivative · entry 1

Harris Carla A · CIK 0001707351 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,801

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 13, 2024 Filed Dec 17, 2024 21:20 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Exercise / conversionEmployee Stock Options (right to buy) · Derivative 9,703 $0.00 Strike: $45.91 $0.00
Disclosure

SEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · derivative · entry 5

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,703 shares

Expires 2025-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 24, 2016, February 24, 2017, and February 27, 2018.

Read SEC document
December 13, 2024 Filed Dec 17, 2024 21:20 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Exercise / conversionEmployee Stock Options (right to buy) · Derivative 13,107 $0.00 Strike: $34.33 $0.00
Disclosure

SEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · derivative · entry 4

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,107 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 23, 2017, 2018, and 2019.

Read SEC document
December 13, 2024 Filed Dec 17, 2024 21:20 UTC
DEBEL MARLENEEVP & Chief Risk Officer
SaleCommon Stock 22,810 $82.88 $1,890,577.20
Disclosure

SEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · nonDerivative · entry 3

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,507

F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $82.83 to $82.931, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
December 13, 2024 Filed Dec 17, 2024 21:20 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Exercise / conversionCommon Stock 9,703 $45.91 $445,464.73
Disclosure

SEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · nonDerivative · entry 2

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,317

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2024 Filed Dec 17, 2024 21:20 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Exercise / conversionCommon Stock 13,107 $34.33 $449,963.31
Disclosure

SEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · nonDerivative · entry 1

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2024 Filed Dec 17, 2024 21:20 UTC
Khalaf MichelDirector · President & CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 26,138 $0.00 Strike: $45.91 $0.00
Disclosure

SEC source: 0001099219-24-000269 · wk-form4_1734470415.xml · derivative · entry 3

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,138 shares

Expires 2025-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Includes 2,787 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.

F4 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 24, 2016, February 24, 2017, and February 27, 2018.

Read SEC document
December 13, 2024 Filed Dec 17, 2024 21:20 UTC
Khalaf MichelDirector · President & CEO
SaleCommon Stock 20,926 $82.84 $1,733,604.01
Disclosure

SEC source: 0001099219-24-000269 · wk-form4_1734470415.xml · nonDerivative · entry 2

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,799

F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on December 13, 2024, and related tax obligations and fees.

F2 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $82.82 to $82.95, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
December 13, 2024 Filed Dec 17, 2024 21:20 UTC
Khalaf MichelDirector · President & CEO
Exercise / conversionCommon Stock 26,138 $45.91 $1,199,995.58
Disclosure

SEC source: 0001099219-24-000269 · wk-form4_1734470415.xml · nonDerivative · entry 1

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 521,725

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:17 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-24-000253 · wk-form4_1727986659.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,291

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:17 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-24-000252 · wk-form4_1727986648.xml · nonDerivative · entry 1

Johnson Jeh C. · CIK 0001707516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,036

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:17 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-24-000251 · wk-form4_1727986638.xml · nonDerivative · entry 1

Harris Carla A · CIK 0001707351 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,785

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:17 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-24-000250 · wk-form4_1727986627.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,102

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:17 UTC GrantCommon Stock 535 $0.00 $0.00
Disclosure

SEC source: 0001099219-24-000249 · wk-form4_1727986616.xml · nonDerivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,270

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:16 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-24-000248 · wk-form4_1727986605.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,006

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:16 UTC GrantCommon Stock 535 $0.00 $0.00
Disclosure

SEC source: 0001099219-24-000247 · wk-form4_1727986593.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,300

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:16 UTC GrantCommon Stock 535 $0.00 $0.00
Disclosure

SEC source: 0001099219-24-000246 · wk-form4_1727986582.xml · nonDerivative · entry 1

MORRISON DENISE M · CIK 0001230166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,180

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:16 UTC
Hay Laura JDirector
GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-24-000245 · wk-form4_1727986571.xml · nonDerivative · entry 1

Hay Laura J · CIK 0002013372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,010

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:16 UTC GrantCommon Stock 535 $0.00 $0.00
Disclosure

SEC source: 0001099219-24-000244 · wk-form4_1727986558.xml · nonDerivative · entry 1

GUTIERREZ CARLOS M · CIK 0001185943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,214

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:15 UTC GrantCommon Stock 535 $81.78 $43,752.30
Disclosure

SEC source: 0001099219-24-000243 · wk-form4_1727986546.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 20:15 UTC GrantCommon Stock 918 $81.78 $75,074.04
Disclosure

SEC source: 0001099219-24-000242 · wk-form4_1727986536.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,831

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
September 10, 2024 Filed Sep 12, 2024 20:33 UTC GrantCommon Stock 586 $74.63 $43,733.18
Disclosure

SEC source: 0001099219-24-000229 · wk-form4_1726173206.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,471

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 10, 2024 Filed Sep 12, 2024 20:33 UTC GrantCommon Stock 294 $74.63 $21,941.22
Disclosure

SEC source: 0001099219-24-000228 · wk-form4_1726173194.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,567

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 10, 2024 Filed Sep 12, 2024 20:33 UTC GrantCommon Stock 252 $74.63 $18,806.76
Disclosure

SEC source: 0001099219-24-000227 · wk-form4_1726173182.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,756

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 10, 2024 Filed Sep 12, 2024 20:32 UTC GrantCommon Stock 14 $74.63 $1,044.82
Disclosure

SEC source: 0001099219-24-000226 · wk-form4_1726173169.xml · nonDerivative · entry 1

Harris Carla A · CIK 0001707351 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 10, 2024 Filed Sep 12, 2024 20:32 UTC GrantCommon Stock 631 $74.63 $47,091.53
Disclosure

SEC source: 0001099219-24-000225 · wk-form4_1726173157.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,913

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 10, 2024 Filed Sep 12, 2024 20:32 UTC GrantCommon Stock 43 $74.63 $3,209.09
Disclosure

SEC source: 0001099219-24-000224 · wk-form4_1726173146.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,765

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 10, 2024 Filed Sep 12, 2024 20:32 UTC GrantCommon Stock 141 $74.63 $10,522.83
Disclosure

SEC source: 0001099219-24-000223 · wk-form4_1726173134.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,465

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.